From USFDA
Zydus Cadila has received the final approval from the USFDA to market Candesartan Cilexetil Tablets USP 4mg, 8mg, 16mg and 32mg. The drug is used to treat high blood pressure (hypertension) in adults and will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad.Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)